Antibody News and Research

RSS
An antibody is a blood protein that is produced in response to and counteracts an antigen. Antibodies are produced in response to disease and help the body fight against the particular disease. In this way, antibodies help the body develop an immunity to disease.

Further Reading

Study reports overall response of HER2-low breast cancer patients to neoadjuvant T-DXd treatment

Study reports overall response of HER2-low breast cancer patients to neoadjuvant T-DXd treatment

Exploring immunogenicity, boosting efficacy and safety of modified vaccinia Ankara-Bavarian Nordic vaccine

Exploring immunogenicity, boosting efficacy and safety of modified vaccinia Ankara-Bavarian Nordic vaccine

Pre-existing SARS-CoV-2 antibodies may increase the breadth of mRNA vaccines, study suggests

Pre-existing SARS-CoV-2 antibodies may increase the breadth of mRNA vaccines, study suggests

Research extends the powerful tool of immunotherapy to autoimmune diseases

Research extends the powerful tool of immunotherapy to autoimmune diseases

The critical role of flow cytometry in CAR+ T-Cell trials

The critical role of flow cytometry in CAR+ T-Cell trials

Vaccine MVA-BN shows consistent, robust immunogenicity and safety results

Vaccine MVA-BN shows consistent, robust immunogenicity and safety results

Study explores histopathological, serological, and clinical characteristics of PASC in patients with mild COVID-19

Study explores histopathological, serological, and clinical characteristics of PASC in patients with mild COVID-19

Study provides understanding of SARS-CoV-2 pulmonary infection long-term effects at the microanatomical, cellular, and molecular level

Study provides understanding of SARS-CoV-2 pulmonary infection long-term effects at the microanatomical, cellular, and molecular level

Impact of COVID-19 booster vaccination and breakthrough infection

Impact of COVID-19 booster vaccination and breakthrough infection

Researchers develop a polyvalent lipid nanoparticle mRNA vaccine against Monkeypox virus

Researchers develop a polyvalent lipid nanoparticle mRNA vaccine against Monkeypox virus

Researchers uncover the host protease CAPN2 as a novel host factor that aids the infection of SARS-CoV-2

Researchers uncover the host protease CAPN2 as a novel host factor that aids the infection of SARS-CoV-2

Mucosal IgA fused nanobody as a non-invasive, cost-effective prophylaxis and therapeutic option against major SARS-CoV-2 variants

Mucosal IgA fused nanobody as a non-invasive, cost-effective prophylaxis and therapeutic option against major SARS-CoV-2 variants

New tool may help better predict resistance to immunoglobulin therapy among children with Kawasaki disease

New tool may help better predict resistance to immunoglobulin therapy among children with Kawasaki disease

Vaccination against pertussis in pregnancy and outstanding scientific questions

Vaccination against pertussis in pregnancy and outstanding scientific questions

Antibody responses engendered by maternal SARS-CoV-2 vaccination following initial and booster doses in maternal circulation and breastmilk

Antibody responses engendered by maternal SARS-CoV-2 vaccination following initial and booster doses in maternal circulation and breastmilk

First-in-humans test provides promising results for a broadly neutralizing antibody HIV vaccine

First-in-humans test provides promising results for a broadly neutralizing antibody HIV vaccine

Prior infection and vaccination protects against severe outcomes from SARS-CoV-2 Omicron infection

Prior infection and vaccination protects against severe outcomes from SARS-CoV-2 Omicron infection

Novel prefusion S antigen designed by the mutation of the SARS-CoV-2 Spike protein’s trimeric structure

Novel prefusion S antigen designed by the mutation of the SARS-CoV-2 Spike protein’s trimeric structure

The requirement for Fc effector functions to protect against SARS-CoV-2 infection

The requirement for Fc effector functions to protect against SARS-CoV-2 infection

Study provides a framework to guide the development of variant-resistant SARS-CoV-2 vaccines

Study provides a framework to guide the development of variant-resistant SARS-CoV-2 vaccines

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.